MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10096-023-04701-x

Медицинская библиотека · European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023

Longevity of the humoral and cellular responses after SARS-CoV-2 booster vaccinations in immunocompromised patients.

Oyaert Matthijs, De Scheerder Marie-Angélique, Van Herrewege Sophie, Laureys Guy, Van Assche Sofie, Cambron Melissa, Naesens Leslie, Hoste Levi, Claes Karlien, Haerynck Filomeen, Kerre Tessa, Van Laecke Steven, Jacques Peggy, Padalko Elizaveta

СтатьяПеревод в очереди

Аннотация

We assessed the humoral and cellular immune responses after two booster mRNA vaccine administrations [BNT162b2 (Pfizer-BioNTech vaccine)] in cohorts of immunocompromised patients (n = 199) and healthy controls (HC) (n = 54). All patients living with HIV (PLWH) and chronic kidney disease (CKD) patients and almost all (98.2%) of the primary immunodeficiency (PID) patients had measurable antibodies 3 and 6 months after administration of the third and fourth vaccine dose, comparable to the HCs. In contrast, only 53.3% and 83.3% of the multiple sclerosis (MS) and rheumatologic patients, respectively, developed a humoral immune response. Cellular immune response was observed in all PLWH after administration of four vaccine doses. In addition, cellular immune response was positive in 89.6%, 97.8%, 73.3% and 96.9% of the PID, MS, rheumatologic and CKD patients, respectively. Unlike the other groups, only the MS patients had a significantly higher cellular immune response compared to the HC group. Administration of additional vaccine doses results in retained or increased humoral and cellular immune response in patients with acquired or inherited immune disorders.

Для цитирования: Oyaert Matthijs, De Scheerder Marie-Angélique, Van Herrewege Sophie, Laureys Guy, Van Assche Sofie, Cambron Melissa, Naesens Leslie, Hoste Levi, Claes Karlien, Haerynck Filomeen, Kerre Tessa, Van Laecke Steven, Jacques Peggy, Padalko Elizaveta. Longevity of the humoral and cellular responses after SARS-CoV-2 booster vaccinations in immunocompromised patients.. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2023. DOI: 10.1007/s10096-023-04701-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.